PubMed

Hemochromatosis and vitamin C.

Herbert V.

Ann Intern Med. 1999 Sep 21;131(6):475-6. No abstract available. PMID: 10498572 [PubMed - indexed for MEDLINE]Related articlesFree article

[Myocardiopathy caused by iron deposition. Treatment with chelating agents]

Rodríguez Reguero JJ, Iglesias Cubero G, Espolita Santos A, López de la Iglesia JM, Enríquez Martín J, Tomás Mauri J, López-Negrete L.

Rev Esp Cardiol. 1985 Sep-Oct;38(5):356-7. Spanish. No abstract available. PMID: 4081244 [PubMed - indexed for MEDLINE]Related articles

[The treatment of post-transfusional hemochromatosis with chelating agents]

Delvaux D, Andrien JM, Fillet G.

Rev Med Liege. 1981 Jun 1;36(11):477-80. French. No abstract available. PMID: 6789438 [PubMed - indexed for MEDLINE]Related articles

Iron metabolism and chelation therapy in hemosiderosis.

Graziano JH.

Curr Top Hematol. 1978;1:127-50. Review. No abstract available. PMID: 400529 [PubMed - indexed for MEDLINE]Related articles

[Effect of desferrioxamine B and 2-(beta-aminoethoxy)cyclohexylaminetetraacetate in experimental hemochromatosis in rats and in primary hemochromatosis of man]

Bohne F, Lessmann J.

Arzneimittelforschung. 1969 Jun;19(6):944-7. German. No abstract available. PMID: 5820039 [PubMed - indexed for MEDLINE]Related articles

Chelation therapy for iron overload.

[No authors listed]

Nutr Rev. 1980 May;38(5):185-7. No abstract available. PMID: 7207885 [PubMed - indexed for MEDLINE]Related articles

Vitamin C, desferrioxamine and iron loading anemias.

Van der Weyden MB.

Aust N Z J Med. 1984 Oct;14(5):593-5. No abstract available. PMID: 6597704 [PubMed - indexed for MEDLINE]Related articles

[Further experiences with iron-chelating therapy (desferrioxamine and ascorbic acid) in siderochromatosis and Cooley's disease]

Cartei G, Cazzavillan M, Chisesi T, Battista R, Barbui T, Dini E.

Minerva Med. 1978 Mar 17;69(13):811-21. Italian. No abstract available. PMID: 643223 [PubMed - indexed for MEDLINE]Related articles

Reversal of cardiac complications by deferiprone and deferoxamine combination therapy in a patient affected by a severe type of juvenile hemochromatosis (JH).

Fabio G, Minonzio F, Delbini P, Bianchi A, Cappellini MD.

Blood. 2007 Jan 1;109(1):362-4. Epub 2006 Sep 7.PMID: 16960153 [PubMed - indexed for MEDLINE]Related articlesFree article

[Hemochromatosis in the age of genetics]

Buffet C.

Presse Med. 2007 Sep;36(9 Pt 2):1269-70. Epub 2007 Jun 8. French. No abstract available. PMID: 17560763 [PubMed - indexed for MEDLINE]Related articles

[Idiopathic hemochromatosis. Therapeutics]

Pergola F.

Presse Med. 1967 May 20;75(24):1221-2. French. No abstract available. PMID: 4960744 [PubMed - indexed for MEDLINE]Related articles

Effect of ascorbic acid on desferrioxamine-induced urinary iron excretion in idiopathic hemochromatosis.

Conte D, Brunelli L, Ferrario L, Mandelli C, Quatrini M, Velio P, Bianchi PA.

Acta Haematol. 1984;72(2):117-20.PMID: 6437113 [PubMed - indexed for MEDLINE]Related articles

Iron overload related to excessive vitamin C intake.

Mallory MA, Sthapanachai C, Kowdley KV.

Ann Intern Med. 2003 Sep 16;139(6):532-3. No abstract available. PMID: 13679342 [PubMed - indexed for MEDLINE]Related articlesFree article

Neonatal hemochromatosis: outcomes of pharmacologic and surgical therapies.

Sigurdsson L, Reyes J, Kocoshis SA, Hansen TW, Rosh J, Knisely AS.

J Pediatr Gastroenterol Nutr. 1998 Jan;26(1):85-9.PMID: 9443126 [PubMed - indexed for MEDLINE]Related articles

Combined vitamin E and vitamin C supplement use and risk of cardiovascular disease mortality.

Simon JA.

Arch Intern Med. 2002 Dec 9-23;162(22):2630; author reply 2630. No abstract available. PMID: 12456238 [PubMed - indexed for MEDLINE]Related articles

The effect of ascorbic acid deficiency on desferrioxamine-induced urinary iron excretion.

Wapnick AA, Lynch SR, Charlton RW, Seftel HC, Bothwell TH.

Br J Haematol. 1969 Dec;17(6):563-8. No abstract available. PMID: 5357744 [PubMed - indexed for MEDLINE]Related articles

Treatment of primary hemochromatosis with deferoxamine.

Young N, Henry W, Nienhuis AW.

JAMA. 1979 Mar 16;241(11):1152-4. No abstract available. PMID: 762769 [PubMed - indexed for MEDLINE]Related articles

[Biologically active hydroxamic acids--iron complexons]

Kol'tsova GN, Mel'nikovskaia NN, Likhodzievskiĭ KG, Rozenberg GIa.

Gematol Transfuziol. 1984 Sep;29(9):56-9. Review. Russian. No abstract available. PMID: 6394425 [PubMed - indexed for MEDLINE]Related articles

Chelating agents in medicine.

[No authors listed]

Br Med J. 1971 May 1;2(5756):270-2. No abstract available. PMID: 4102017 [PubMed - indexed for MEDLINE]Related articlesFree article

Clinical usefulness of iron chelating agents.

Waxman HS, Brown EB.

Prog Hematol. 1969;6:338-73. Review. No abstract available. PMID: 4976246 [PubMed - indexed for MEDLINE]Related articles